trending Market Intelligence /marketintelligence/en/news-insights/trending/8OUS5YjkGTDcyJNwpZ8_sw2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Cardiovascular Systems buys artery device from Gardia Medical

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Cardiovascular Systems buys artery device from Gardia Medical

Cardiovascular Systems Inc. acquired Gardia Medical Ltd.'s Wirion embolic protection system and related assets.

The Wirion embolic protection system is used to capture debris associated with all types of peripheral vascular intervention procedures, or PVI, to treat peripheral artery disease.

PVI refers to minimally invasive procedures that remove plaque and enable blood to flow through arteries without surgically opening any limbs.

The device was granted Europe's CE mark in June 2015 and U.S. Food and Drug Administration clearance in March 2018.

The acquisition is set to improve Cardiovascular Systems' portfolio of products to save limbs and improve outcomes for patients undergoing complex peripheral interventions, according to the company.

Gardia, a wholly owned unit of Israel's Allium Medical Solutions Ltd., will retain rights to the device for angioplasty and stenting procedures in carotid arteries.

St. Paul, Minn.-based Cardiovascular Systems develops and manufactures devices to treat vascular and coronary diseases.